May 15 (Reuters) – At least 20 people in Japan who took Amgen’s rare disease drug have died, while 22 others developed potentially fatal liver injuries, the Wall Street Journal reported on Friday, citing partner Kissei Pharmaceutical.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Shailesh Kuber)
Comments